Allurion Technologies (ALUR) EBT Margin (2022 - 2026)
Allurion Technologies (ALUR) posted EBT Margin of 206.07% for Q1 2026, down 13.58% on a QoQ basis from 181.43% in Q4 2025, and down 18088.0% year-over-year from N/an in Q1 2025.
Allurion Technologies (ALUR) EBT Margin (2022 - 2026) Analysis & Trends
Allurion Technologies' EBT Margin history runs 5 years deep, the most recent figure standing at 206.07% for Q1 2026.
- Quarterly EBT Margin fell 18088.0% year-over-year to 206.07% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 268.28% (down 23310.0% YoY) and the FY2025 annual result came in at 191.25%, down 17107.0% from the prior year.
- EBT Margin was 206.07% for Q1 2026 at Allurion Technologies, down from 181.43% in the prior quarter.
- Across five years, EBT Margin topped out at 164.06% in Q3 2024 and bottomed at 446.76% in Q3 2025.
- A 5-year average of 127.38% and a median of 122.46% in 2023 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2024 — EBT Margin soared 28272 bps — and 2025, when it tumbled 61082 bps.
- Allurion Technologies' EBT Margin stood at 67.59% in 2022, then slumped by 281 bps to 257.63% in 2023, then jumped by 37 bps to 162.76% in 2024, then retreated by 11 bps to 181.43% in 2025, then slipped by 14 bps to 206.07% in 2026.
- Business Quant data shows ALUR's EBT Margin at 206.07% in Q1 2026, 181.43% in Q4 2025, and 446.76% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 22.61% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.84% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | -206.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -206.07% |
| Dec 31, 2025 | -181.43% |
| Sep 30, 2025 | -446.76% |
| Jun 30, 2025 | -274.99% |
| Mar 31, 2025 | -25.20% |
| Dec 31, 2024 | -162.76% |
| Sep 30, 2024 | 164.06% |
| Jun 30, 2024 | -70.18% |
| Mar 31, 2024 | 22.08% |
| Dec 31, 2023 | -257.63% |
| Sep 30, 2023 | -118.66% |
| Jun 30, 2023 | -169.55% |
| Mar 31, 2023 | -126.27% |
| Dec 31, 2022 | -67.59% |
| Sep 30, 2022 | -83.90% |
| Jun 30, 2022 | -33.26% |